|
Taper ii.Medwatch sent to fda on 02/04/2016.Device evaluation summary: the device was returned for analysis, and only the port tubing was received.Visual inspection was performed, and noted the tubing appeared discolored.Visual inspection also noted a tear on the tubing approximately 6 cm from the taper junction, as well as a second tear on the end which would connect to the ss connector.Leak testing was performed and observed leakage of the device, and confirmed the reported failure.Device labeling addresses the reported event as follows: adverse events: unplanned deflation of the band may occur due to leakage from the band, the port or the connecting tubing.Precautions: failure to create a stable, smooth path for the access port tubing, without sharp turns or bends, can result in tubing breaks and leakage.In order to avoid incorrect placement, the port should be placed lateral to the trocar opening.A pocket must be created for the port so that it is placed far enough from the trocar path to avoid abrupt kinking of the tubing.The tubing path should point in the direction of the access port connector so that the tubing will form a straight line with a gentle arching transition into the abdomen.Warnings: patients should be advised that the lap-band system is a long-term implant.Explant (removal) and replacement surgery may be indicated at any time.Medical management of adverse reactions may include explantation.Revision surgery for explantation and replacement may also be indicated to achieve patient satisfaction.
|